Read the latest news from Saama.
A Seminal Moment for Life Sciences In this PharmaVOICE article, Saama’s Chief Strategy Officer Sagar Anisingaraju explains why sponsors and CROs that fail to adopt
As AI Continues to Entice Big Pharma, a Carlyle-Led Drugmaker Syndicate Shells Out $430M for Cloud Computing Player Pharma’s AI Revolution Takes Big Financial Step
Private Equity Group Gets Control of Campbell-Based Saama Technologies in $430M Deal Pharma Venture Funds See Value in Saama’s Leadership The Silicon Valley Business Journal
Carlyle and co-investors including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund (“Merck GHI”), McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners
Private Equity Powerhouse Leads Group of Investors Bullish on AI Leading business publication Forbes broke the news of Saama’s $430 million funding deal with a
Thanks to the Global Pandemic, AI in Clinical Trials Is Here to Stay In this special feature for PharmaVOICE’s October 2021 Showcase on AI, Saama’s
CAMPBELL, Calif.–Saama Technologies, the #1 AI-powered clinical analytics company, will participate in the Morgan Stanley 19th Annual Global Healthcare Conference on Friday, September 10. Company
Saama’s customized cloud strategy aligned with AWS Saama Smart Applications for fast-tracked clinical innovation supported by AWS Saama ensures faster, safer clinical development via AWS
AI Is More than Just Business Process Efficiency In this forward-looking article, Saama’s Jonathan Burr, Senior VP, Clinical Platform Strategy, shows how AI is informing
